Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
Tim Harrison, Pascal Chanez, Francesco Menzella, Giorgio Walter Canonica et autres
179 citationsThe Lancet Respiratory Medicine